Top 5 Most Read RNS's on Vox Markets for Monday 26th September 2022
Episode 916, Sep 26, 2022, 06:58 AM
5. Versarien #VRS - BiaBrazil to utilise Graphene-Wear Technology
BiaBrazil, a leading Brazilian sports and active wear manufacturer, has announced it has signed a commercial agreement with Versarien which will see the integration of Versarien's Graphene-Wear™ technology into a new range of women and men's active wear garments.
4. Guild Esports #GILD - Guild's largest sponsorship deal signed with Sky
This deal is Guild's largest to date and is payable exclusively in cash via instalments over the period of the contract. It is the eighth revenue-generating sponsorship signed by the Company since its IPO on the London Stock Exchange.
3. Genedrive #GDR - NICE to accelerate evaluation of Genedrive test
The UK's National Institute for Health and Clinical Excellence ("NICE") has transferred the evaluation of the Genedrive® MT-RNR1 test to a new Early Value Assessment Programme.
2. Vast Resources #VAST - Placing to raise £656,000 and Baita Plai Operational Update
The net cash raised will ensure the Company’s operations continue to be supported over the coming weeks as a consequence of a delay in exporting its latest concentrate shipment, as well as the start of the underground production ramp up occurring later in Q3 2022 than originally anticipated.
1. Avacta Group #AVCT - Notice of Results
Its unaudited interim results for the six months ended 30 June 2022 will be released on 29 September 2022.
BiaBrazil, a leading Brazilian sports and active wear manufacturer, has announced it has signed a commercial agreement with Versarien which will see the integration of Versarien's Graphene-Wear™ technology into a new range of women and men's active wear garments.
4. Guild Esports #GILD - Guild's largest sponsorship deal signed with Sky
This deal is Guild's largest to date and is payable exclusively in cash via instalments over the period of the contract. It is the eighth revenue-generating sponsorship signed by the Company since its IPO on the London Stock Exchange.
3. Genedrive #GDR - NICE to accelerate evaluation of Genedrive test
The UK's National Institute for Health and Clinical Excellence ("NICE") has transferred the evaluation of the Genedrive® MT-RNR1 test to a new Early Value Assessment Programme.
2. Vast Resources #VAST - Placing to raise £656,000 and Baita Plai Operational Update
The net cash raised will ensure the Company’s operations continue to be supported over the coming weeks as a consequence of a delay in exporting its latest concentrate shipment, as well as the start of the underground production ramp up occurring later in Q3 2022 than originally anticipated.
1. Avacta Group #AVCT - Notice of Results
Its unaudited interim results for the six months ended 30 June 2022 will be released on 29 September 2022.